205 related articles for article (PubMed ID: 36479958)
1. Active site architecture of coproporphyrin ferrochelatase with its physiological substrate coproporphyrin III: Propionate interactions and porphyrin core deformation.
Dali A; Gabler T; Sebastiani F; Destinger A; Furtmüller PG; Pfanzagl V; Becucci M; Smulevich G; Hofbauer S
Protein Sci; 2023 Jan; 32(1):e4534. PubMed ID: 36479958
[TBL] [Abstract][Full Text] [Related]
2. Substrate specificity and complex stability of coproporphyrin ferrochelatase is governed by hydrogen-bonding interactions of the four propionate groups.
Gabler T; Sebastiani F; Helm J; Dali A; Obinger C; Furtmüller PG; Smulevich G; Hofbauer S
FEBS J; 2022 Mar; 289(6):1680-1699. PubMed ID: 34719106
[TBL] [Abstract][Full Text] [Related]
3. Crystal structures and calorimetry reveal catalytically relevant binding mode of coproporphyrin and coproheme in coproporphyrin ferrochelatase.
Hofbauer S; Helm J; Obinger C; Djinović-Carugo K; Furtmüller PG
FEBS J; 2020 Jul; 287(13):2779-2796. PubMed ID: 31794133
[TBL] [Abstract][Full Text] [Related]
4. Revisiting catalytic His and Glu residues in coproporphyrin ferrochelatase - unexpected activities of active site variants.
Gabler T; Dali A; Bellei M; Sebastiani F; Becucci M; Battistuzzi G; Furtmüller PG; Smulevich G; Hofbauer S
FEBS J; 2024 May; 291(10):2260-2272. PubMed ID: 38390750
[TBL] [Abstract][Full Text] [Related]
5. Iron insertion into coproporphyrin III-ferrochelatase complex: Evidence for an intermediate distorted catalytic species.
Gabler T; Dali A; Sebastiani F; Furtmüller PG; Becucci M; Hofbauer S; Smulevich G
Protein Sci; 2023 Nov; 32(11):e4788. PubMed ID: 37743577
[TBL] [Abstract][Full Text] [Related]
6. The coproporphyrin ferrochelatase of
Hobbs C; Reid JD; Shepherd M
Biochem J; 2017 Oct; 474(20):3513-3522. PubMed ID: 28864672
[TBL] [Abstract][Full Text] [Related]
7. Porphyrin interactions with wild-type and mutant mouse ferrochelatase.
Franco R; Ma JG; Lu Y; Ferreira GC; Shelnutt JA
Biochemistry; 2000 Mar; 39(10):2517-29. PubMed ID: 10704201
[TBL] [Abstract][Full Text] [Related]
8. Proximal ligand tunes active site structure and reactivity in bacterial L. monocytogenes coproheme ferrochelatase.
Dali A; Sebastiani F; Gabler T; Frattini G; Moreno DM; Estrin DA; Becucci M; Hofbauer S; Smulevich G
Spectrochim Acta A Mol Biomol Spectrosc; 2024 May; 313():124120. PubMed ID: 38479228
[TBL] [Abstract][Full Text] [Related]
9. Human ferrochelatase: characterization of substrate-iron binding and proton-abstracting residues.
Sellers VM; Wu CK; Dailey TA; Dailey HA
Biochemistry; 2001 Aug; 40(33):9821-7. PubMed ID: 11502175
[TBL] [Abstract][Full Text] [Related]
10. Molecular dynamics simulations of mouse ferrochelatase variants: what distorts and orientates the porphyrin?
Szefczyk B; Cordeiro MN; Franco R; Gomes JA
J Biol Inorg Chem; 2009 Sep; 14(7):1119-28. PubMed ID: 19543923
[TBL] [Abstract][Full Text] [Related]
11. Binding of protoporphyrin IX and metal derivatives to the active site of wild-type mouse ferrochelatase at low porphyrin-to-protein ratios.
Lu Y; Sousa A; Franco R; Mangravita A; Ferreira GC; Moura I; Shelnutt JA
Biochemistry; 2002 Jul; 41(26):8253-62. PubMed ID: 12081474
[TBL] [Abstract][Full Text] [Related]
12. The conserved active-site loop residues of ferrochelatase induce porphyrin conformational changes necessary for catalysis.
Shi Z; Franco R; Haddad R; Shelnutt JA; Ferreira GC
Biochemistry; 2006 Mar; 45(9):2904-12. PubMed ID: 16503645
[TBL] [Abstract][Full Text] [Related]
13. Substrate interactions with human ferrochelatase.
Medlock A; Swartz L; Dailey TA; Dailey HA; Lanzilotta WN
Proc Natl Acad Sci U S A; 2007 Feb; 104(6):1789-93. PubMed ID: 17261801
[TBL] [Abstract][Full Text] [Related]
14. Resonance Raman Spectroscopic Examination of Ferrochelatase-induced Porphyrin Distortion.
Franco R; Al-Karadaghi S; Ferreira GC
J Porphyr Phthalocyanines; 2011 May; 15(5):357-363. PubMed ID: 21776189
[TBL] [Abstract][Full Text] [Related]
15. Dissection of porphyrin-induced conformational dynamics in the heme biosynthesis enzyme ferrochelatase.
Asuru AP; An M; Busenlehner LS
Biochemistry; 2012 Sep; 51(36):7116-27. PubMed ID: 22897320
[TBL] [Abstract][Full Text] [Related]
16. Nickel(II) chelatase variants directly evolved from murine ferrochelatase: porphyrin distortion and kinetic mechanism.
McIntyre NR; Franco R; Shelnutt JA; Ferreira GC
Biochemistry; 2011 Mar; 50(9):1535-44. PubMed ID: 21222436
[TBL] [Abstract][Full Text] [Related]
17. Altered orientation of active site residues in variants of human ferrochelatase. Evidence for a hydrogen bond network involved in catalysis.
Dailey HA; Wu CK; Horanyi P; Medlock AE; Najahi-Missaoui W; Burden AE; Dailey TA; Rose J
Biochemistry; 2007 Jul; 46(27):7973-9. PubMed ID: 17567154
[TBL] [Abstract][Full Text] [Related]
18. Product release rather than chelation determines metal specificity for ferrochelatase.
Medlock AE; Carter M; Dailey TA; Dailey HA; Lanzilotta WN
J Mol Biol; 2009 Oct; 393(2):308-19. PubMed ID: 19703464
[TBL] [Abstract][Full Text] [Related]
19. A pi-helix switch selective for porphyrin deprotonation and product release in human ferrochelatase.
Medlock AE; Dailey TA; Ross TA; Dailey HA; Lanzilotta WN
J Mol Biol; 2007 Nov; 373(4):1006-16. PubMed ID: 17884090
[TBL] [Abstract][Full Text] [Related]
20. Human Ferrochelatase: Insights for the Mechanism of Ferrous Iron Approaching Protoporphyrin IX by QM/MM and QTCP Free Energy Studies.
Wu J; Wen S; Zhou Y; Chao H; Shen Y
J Chem Inf Model; 2016 Dec; 56(12):2421-2433. PubMed ID: 27801584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
